Cargando…
Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions
BACKGROUND: Control of skeletal muscle mass and force production is a complex physiological process involving numerous regulatory systems. Agents that increase skeletal muscle cAMP levels have been shown to modulate skeletal muscle mass and force production. The dopamine 1 receptor and its closely r...
Autores principales: | Reichart, Deborah L, Hinkle, Richard T, Lefever, Frank R, Dolan, Elizabeth T, Dietrich, Jeffrey A, Sibley, David R, Isfort, Robert J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038169/ https://www.ncbi.nlm.nih.gov/pubmed/21269506 http://dx.doi.org/10.1186/1471-2474-12-27 |
Ejemplares similares
-
Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals
por: Hinkle, Richard T, et al.
Publicado: (2011) -
Prevalence and Mechanisms of Skeletal Muscle Atrophy in Metabolic Conditions
por: Jun, Lauren, et al.
Publicado: (2023) -
Video Representation of Dopamine-Responsive Multiple System Atrophy Cerebellar Type
por: Doan, Jonathan, et al.
Publicado: (2021) -
Inflammation: Roles in Skeletal Muscle Atrophy
por: Ji, Yanan, et al.
Publicado: (2022) -
Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy
por: Miller, Spencer G., et al.
Publicado: (2019)